| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192229 | Annals of Allergy, Asthma & Immunology | 2011 | 5 Pages |
Abstract
Although LLRs do not predict SRs, a subgroup (41.7%) of LLR patients experience a higher frequency of SRs during their immunotherapy course. In light of a similar previous study, this association occurs irrespective of whether a dose adjustment protocol is used for LLRs.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Christopher W. MD, Adrienne MSPH, Michael S. MD,